Utility of Laboratory Testing for Children With Seizure in Emergency Department

Seizure Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01123746
• Other study ID #: 98088
• Status: Completed
• Phase: N/A
• First received: May 12, 2010
• Last updated: May 12, 2010
• Start date: October 2009
• Est. completion date: April 2010

Study information

• Verified date: May 2010
• Source: Taipei Medical University WanFang Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

Objective: To evaluate the predisposing factors associated with abnormal laboratory findings in patients who came to the emergency room due to a first seizure.

Methods: Patients were divided into separate groups based on normal and abnormal laboratory results for sodium, potassium, calcium, and glucose. The difference in age, gender, whether this was the first attack, whether there was fever, whether there were gastrointestinal symptoms, the duration and pattern of the seizure, and whether there was a seizure at the emergency department, were evaluated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 500
• Est. completion date: April 2010
• Est. primary completion date: December 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

• Age: less than 18 years old

• The patient came to emergency department due to seizure

• The patient received blood sampling including serum sodium, potassium, calcium and glucose.

Exclusion Criteria:

• The patient came to the outpatient department.

• The patient did not received blood sampling at emergency room.

• The seizure occurred after admission.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Seizure
• Seizures

Locations

Country	Name	City	State
Taiwan	Taipei Medical University-WanFang Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Taipei Medical University WanFang Hospital

Country where clinical trial is conducted

Taiwan,